AU2001284125A1 - Medicine for fighting against sexual dysfunction - Google Patents

Medicine for fighting against sexual dysfunction

Info

Publication number
AU2001284125A1
AU2001284125A1 AU2001284125A AU8412501A AU2001284125A1 AU 2001284125 A1 AU2001284125 A1 AU 2001284125A1 AU 2001284125 A AU2001284125 A AU 2001284125A AU 8412501 A AU8412501 A AU 8412501A AU 2001284125 A1 AU2001284125 A1 AU 2001284125A1
Authority
AU
Australia
Prior art keywords
medicine
sexual dysfunction
fighting against
against sexual
fighting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001284125A
Other languages
English (en)
Inventor
Philippe Gorny
Catherine Pons-Himbert
Olivier Stucker
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Adenomed BV
Original Assignee
Adenomed BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adenomed BV filed Critical Adenomed BV
Publication of AU2001284125A1 publication Critical patent/AU2001284125A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
    • A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
    • A61K31/708—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid having oxo groups directly attached to the purine ring system, e.g. guanosine, guanylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Gynecology & Obstetrics (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
AU2001284125A 2000-08-08 2001-08-08 Medicine for fighting against sexual dysfunction Abandoned AU2001284125A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR00/10435 2000-08-08
FR0010435A FR2812812B1 (fr) 2000-08-08 2000-08-08 Medicament destine notamment a combattre les dysfonctions sexuelles
PCT/FR2001/002579 WO2002011665A2 (fr) 2000-08-08 2001-08-08 Association d'une purine et d'un ains pour le traitement des dysfonctions sexuelles

Publications (1)

Publication Number Publication Date
AU2001284125A1 true AU2001284125A1 (en) 2002-02-18

Family

ID=8853401

Family Applications (2)

Application Number Title Priority Date Filing Date
AU2001284126A Abandoned AU2001284126A1 (en) 2000-08-08 2001-08-08 Use, in combination, of a purine activity and a nonsteroidal anti-inflammatory drug for preparing an anti-thrombotic and/or anti-inflammatory drug
AU2001284125A Abandoned AU2001284125A1 (en) 2000-08-08 2001-08-08 Medicine for fighting against sexual dysfunction

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AU2001284126A Abandoned AU2001284126A1 (en) 2000-08-08 2001-08-08 Use, in combination, of a purine activity and a nonsteroidal anti-inflammatory drug for preparing an anti-thrombotic and/or anti-inflammatory drug

Country Status (13)

Country Link
US (2) US20030139368A1 (pt)
EP (2) EP1309331A2 (pt)
JP (2) JP2004505897A (pt)
CN (2) CN1496265A (pt)
AU (2) AU2001284126A1 (pt)
BR (2) BR0112830A (pt)
CA (2) CA2420066A1 (pt)
FR (1) FR2812812B1 (pt)
IL (2) IL154216A0 (pt)
NZ (1) NZ523906A (pt)
RU (2) RU2003105601A (pt)
WO (2) WO2002011735A2 (pt)
ZA (2) ZA200300967B (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7585850B2 (en) * 2004-02-10 2009-09-08 Adenobio N.V. Stable and active complexes of adenosine and adenosine phosphates with aminoalcohols for the treatment of pulmonary artery hypertension, cardiac failure and other diseases
NL1029244C2 (nl) * 2005-06-10 2006-12-12 Ronald Silfried Marlin Middel ter vergroting van het mannelijk geslachtsorgaan.
JP2008106064A (ja) * 2006-09-28 2008-05-08 Honda Trading Corp ｔ−ＰＡ亢進物質及びその製造方法
US20090197892A1 (en) * 2007-08-21 2009-08-06 Nawaz Ahmad Anhydrous compositions useful for attaining enhanced sexual wellness
GB201000196D0 (en) * 2010-01-07 2010-02-24 Galvez Julian M Novel combination
WO2011158904A1 (ja) * 2010-06-18 2011-12-22 株式会社林原生物化学研究所 アデノシンｎ１－オキシドを有効成分として含有する炎症性疾患治療剤
WO2012145098A1 (en) * 2011-04-21 2012-10-26 Saint Louis University Use of adenosine a3 receptor agonists for treatment of neuropathic pain
GB201300435D0 (en) 2013-01-10 2013-02-27 Medical Res Council Benzylideneguanidine Derivatives and Therapeutic Use for the Treatment of Protein Misfolding Diseases
MA40687A (fr) * 2014-04-10 2017-03-28 Ifom Fondazione St Firc Di Oncologia Molecolare Méthodes et compositions de traitement de malformation vasculaire

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU8379182A (en) * 1981-06-04 1982-12-09 Procter & Gamble Company, The Composition of salicylates and purine derivatives
US5242391A (en) * 1990-04-25 1993-09-07 Alza Corporation Urethral insert for treatment of erectile dysfunction
GB9608408D0 (en) * 1996-04-23 1996-06-26 Adams Michael A Treatment of erectile dysfunction
US5847003A (en) * 1996-06-04 1998-12-08 Avon Products, Inc. Oxa acids and related compounds for treating skin conditions

Also Published As

Publication number Publication date
CA2419042A1 (fr) 2002-02-14
BR0112830A (pt) 2003-06-24
CN1496265A (zh) 2004-05-12
JP2004505897A (ja) 2004-02-26
FR2812812B1 (fr) 2002-10-11
BR0112908A (pt) 2003-06-24
WO2002011735A3 (fr) 2002-08-08
FR2812812A1 (fr) 2002-02-15
JP2004505921A (ja) 2004-02-26
ZA200300966B (en) 2004-02-09
CN1468104A (zh) 2004-01-14
NZ523906A (en) 2004-09-24
WO2002011735A2 (fr) 2002-02-14
WO2002011665A3 (fr) 2002-08-08
EP1311273A2 (fr) 2003-05-21
CA2420066A1 (fr) 2002-02-14
US20030139368A1 (en) 2003-07-24
ZA200300967B (en) 2004-02-25
IL154215A0 (en) 2003-07-31
EP1309331A2 (fr) 2003-05-14
WO2002011665A2 (fr) 2002-02-14
US20030139371A1 (en) 2003-07-24
IL154216A0 (en) 2003-07-31
AU2001284126A1 (en) 2002-02-18
RU2003105601A (ru) 2004-09-10
RU2003105600A (ru) 2004-08-10

Similar Documents

Publication Publication Date Title
AU2001252135A1 (en) Therapeutic agents
AU2002222853A1 (en) Therapeutic compounds
AU2002218250A1 (en) Medicament dispenser
AU2002242883A1 (en) Medicament dispenser
AU2002251238A1 (en) Medicament dispenser
AU2002358805A1 (en) Medicament dispenser
AU2001269529A1 (en) Medicine comprising dicyanopyridine derivative
AU2002223562A1 (en) Medicament dispenser
AU2002253039A1 (en) Tramadol-based medicament
AU2001274649A1 (en) Topical preparation of alprostadil for the treatment of erectile dysfunction
AU6900201A (en) Breath-controlled therapeutic inhalation device
AU2001243515A1 (en) Combination drug therapy
AU2002221099A1 (en) Combination drugs
AU2001284125A1 (en) Medicine for fighting against sexual dysfunction
AU3918501A (en) Atomiser
AU2001278680A1 (en) Erectile dysfunction remedies containing prostaglandin derivatives as the activeingredient
AU2001232244A1 (en) Drug comprising combination
AU7652400A (en) Novel combination for the treatment of sexual dysfunction
AU2001273903A1 (en) Therapeutic agents
AU2001275696A1 (en) Therapeutic agent
AU2002215902A1 (en) Medicament dispenser
PH12001001922B1 (en) Crystalline therapeutic agent.
AU2002336782A1 (en) Penis vibrator
AU2002228911A1 (en) Methods for inhibiting pain
AU2002223437A1 (en) Medicament dispenser

Legal Events

Date Code Title Description
MK4 Application lapsed section 142(2)(d) - no continuation fee paid for the application